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Cardiac fibroblasts regulate formation of extracellu-
lar matrix in the heart, playing key roles in cardiac
remodeling and hypertrophy. In this study, we sought to
characterize cross-talk between Gq and Gs signaling
pathways and its impact on modulating collagen synthe-
sis by cardiac fibroblasts. Angiotensin II (ANG II) acti-
vates cell proliferation and collagen synthesis but also
potentiates cyclic AMP (cAMP) production stimulated
by -adrenergic receptors (-AR). The potentiation of
-AR-stimulated cAMP production by ANG II is reduced
by phospholipase C inhibition and enhanced by overex-
pression of Gq. Ionomycin and thapsigargin increased
intracellular Ca2 levels and potentiated isoproterenol-
and forskolin-stimulated cAMP production, whereas
chelation of Ca2 with 1,2-bis(2-aminophenoxy)ethane-
N,N,N,N-tetraacetic acid/AM inhibited such potentia-
tion. Inhibitors of tyrosine kinases, protein kinase C, or
G did not alter this cross-talk. Immunoblot analyses
showed prominent expression of adenylyl cyclase 3
(AC3), a Ca2-activated isoform, along with AC2, AC4,
AC5, AC6, and AC7. Of those isoforms, only AC3 and
AC5/6 proteins were detected in caveolin-rich fractions.
Overexpression of AC6 increased AR-stimulated cAMP
accumulation but did not alter the size of the ANG II
potentiation, suggesting that the cross-talk is AC iso-
form-specific. Isoproterenol-mediated inhibition of se-
rum-stimulated collagen synthesis increased from 31 to
48% in the presence of ANG II, indicating that AR-
regulated collagen synthesis increased in the presence
of ANG II. These data indicate that ANG II potentiates
cAMP formation via Ca2-dependent activation of AC
activity, which in turn attenuates collagen synthesis
and demonstrates one functional consequence of cross-
talk between Gq and Gs signaling pathways in cardiac
fibroblasts.
Cardiac hypertrophy is associated with increased cardiac
mass, a gradual decline in contractile function and eventual
heart failure. The remodeling associated with these changes
involves an altered balance of synthesis and degradation of
extracellular matrix (ECM)1 by cardiac fibroblasts and can lead
to abnormal accumulation of ECM in the interstitial space (i.e.
fibrosis) (1, 2). Several G protein-coupled receptors (GPCR)
that signal through Gq have been implicated in the pathogen-
esis of cardiac hypertrophy and failure (3, 4). Conversely,
GPCRs that signal via Gs may inhibit collagen deposition by
cardiac fibroblasts (5).
Two major pro-fibrotic signals in the heart are cytokines,
such as transforming growth factor-, and the peptide hormone
ANG II, both of which increase collagen synthesis by cardiac
fibroblasts (6, 7). ANG II also inhibits matrix metalloprotein-
ase expression by cardiac fibroblasts, thereby attenuating deg-
radation of ECM proteins (8). An anti-fibrotic role for cAMP is
supported by evidence that adenosine and prostacyclin inhibit
cardiac fibroblast proliferation and collagen synthesis through
activation of A2b and prostanoid receptors, respectively, which
each couple via Gs, to enhanced cAMP production (9, 10). -Ad-
renergic receptors have been shown to stimulate fibroblast
proliferation via epidermal growth factor receptor transactiva-
tion (11) but their role in regulating collagen synthesis in
cardiac fibroblasts is poorly documented.
Adenylyl cyclase (AC) catalyzes the synthesis of cAMP and
its expression limits the ability of a cardiac cell to maximally
produce this second messenger (12, 13). Nine different trans-
membrane AC isoforms exist, each with different amino acid
sequence, tissue and chromosomal distribution, and regulation
(14). Differences in regulation include stimulation or inhibition
by G, Ca2, and various protein kinases. AC5 and AC6,
which are the predominant isoforms expressed in cardiac myo-
cytes (15), represent a subfamily of ACs that are related in
structure and regulation. These isoforms are inhibited by pro-
tein kinase A, Ca2, Gi, G, and nitric oxide (14, 16, 17). By
contrast, AC1, AC3, and AC8 are stimulated by Ca2/calmod-
ulin (yet AC3 can also be inhibited by calmodulin kinase-II)
(14, 18, 19). AC2 and AC4 are activated by G and AC2 and
AC7 can be activated by phosphorylation by protein kinase A
and/or PKC (14). Thus, the AC isoform expression in a cell
determines the interaction between cAMP production and
other signal transduction cascades.
Meszaros et al. (20) have recently described a signaling
“cross-talk” between two key GPCR signal transduction path-
ways in cardiac fibroblasts. Isoproterenol (ISO), a -adrenergic
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receptor (AR) agonist, activates Gs and stimulates cAMP pro-
duction 10-fold over basal levels. ANG II activates Gq-coupled
angiotensin receptors that, by themselves, do not alter cAMP
production in cardiac fibroblasts, but in combination with ISO
potentiate the AR response, resulting in a 2-fold potentiation
of ISO-stimulated cAMP production. The goal of the present
study was to identify the molecular mechanism and physiolog-
ical consequence of the cross-talk between these two signaling
pathways in cardiac fibroblasts. The current data indicate that
Gq-mediated elevation of intracellular Ca
2 induced by ANG II
potentiates Gs-stimulated cAMP formation, probably via stim-
ulation of AC3. Moreover, we show that the potentiation is
functionally relevant: combined treatment of cardiac fibro-
blasts with ANG II and ISO inhibits ANG II-promoted collagen
synthesis more so than ISO alone. Thus, we identify an endog-
enous signaling pathway by which intracellular Ca2 enhances
cAMP production and limits collagen synthesis, and perhaps
fibrosis, in the heart.
EXPERIMENTAL PROCEDURES
Materials—Cell culture reagents were obtained from Invitrogen. Pri-
mary antibodies to AC isoforms and all secondary antibodies were
obtained from Santa Cruz Biotechnology. Antibodies to caveolin were
from BD Pharmingen. ANG II, UTP, Fura-2/AM, forskolin, and
BAPTA/AM were obtained from Calbiochem. All other drugs and re-
agents were of reagent grade and obtained from Sigma.
Preparation and Culture of Adult Rat Cardiac Fibroblasts—Cardiac
fibroblasts were prepared from adult male 250–300-g Sprague-Dawley
rat hearts. Following rapid excision of the hearts, the ventricles were
isolated, minced, pooled, and placed in a collagenase/pancreatin diges-
tion solution. After sequential digestions, the fibroblasts were pelleted
and resuspended in Dulbecco’s modified Eagle’s medium (DMEM) sup-
plemented with penicillin, streptomycin, fungizone, and 10% fetal bo-
vine serum (FBS, Gemini Bio-Products). After a 30-min period of at-
tachment to uncoated culture plates, cells that were weakly attached or
unattached were rinsed free and discarded. After 2–3 days, confluent
cultures were amplified by trypsinization and seeding onto new dishes.
For signaling assays, only early passage (3) cells grown to 80–90%
confluency were used. The purity of these cultures was greater than
95% cardiac fibroblasts as determined by positive staining for vimentin
and negative staining for smooth muscle actin and von Willebrand
factor, as previously described (21).
Adenoviral Gene Transfer to Cardiac Fibroblasts—Wild-type Gq was
cloned into the PACCMVpLpA shuttle vector for production of adeno-
virus, as previously described (3). We found that a titer of 200 virus
particles per cell was optimal for Gq expression without cytotoxicity, as
determined by trypan blue exclusion and morphological examination
with phase-contrast light microscopy. We used 1000 viral particles per
cell of an adenovirus construct to maximally overexpress the murine
adenylyl cyclase type 6 (AC6) gene, produced as described previously
(22). Cardiac fibroblasts were infected with the appropriate virus and
incubated at 37 °C 18–24 h in serum-free DMEM prior to the assays.
Preliminary experiments using LacZ expression and -galactosidase
staining indicated that the efficiency of the adenoviral construct to
increase gene expression was 40% (data not shown).
Quantitation of cAMP Production—Cardiac fibroblasts cultured on
24-well plates were washed three times with 37 °C serum-free and
NaHCO3-free DMEM supplemented with 20 mM HEPES, pH 7.4. Cells
were equilibrated for 30 min, then assayed for cAMP accumulation by
incubation with drugs of interest in the presence of 0.2 mM isobutylm-
ethylxanthine for 10 min. When antagonists or inhibitors were used,
these agents were equilibrated with cells for 15 min before addition of
agonists. Assay medium was aspirated and 250 l of ice-cold trichloro-
acetic acid (7.5% w/v) was immediately added to each well to terminate
reactions. Trichloroacetic acid extracts were assayed for cAMP content
by either Direct ELISA kit (Assay Designs) or radioimmunoassay as
described previously (22). Data were corrected for the amount of total
acid-precipitable protein per well. In other studies, AC activity was
measured in cardiac fibroblast membranes as previously described (23).
Briefly, membranes were prepared by rinsing cells twice in ice-cold
phosphate-buffered saline then scraping cells into hypotonic homoge-
nizing buffer (30 mM Na-HEPES, 5 mM MgCl2, 1 mM EGTA, 2 mM
dithiothreitol, pH 7.5) and homogenizing with 20 strokes in a Dounce
homogenizer. Homogenate was spun at 300  g for 5 min at 4 °C.
Supernatant was then transferred to a clean centrifuge tube and spun
at 5,000  g for 10 min. Pellet was suspended in membrane buffer (30
mM Na-HEPES, 5 mM MgCl2, 2 mM dithiothreitol, pH 7.5) to attain 1
mg/ml total protein concentration. Assay was conducted by adding 30 l
of membranes into tubes containing assay buffer (30 mM Na-HEPES,
100 mM NaCl, 1 mM EGTA, 10 mM MgCl2, 1 mM isobutylmethylxan-
thine, 1 mM ATP, 10 mM phosphocreatine, 5 M GTP, 60 units/ml
creatine phosphokinase, and 0.1% bovine serum albumin, pH 7.5) and
drugs of interest. The mixture was incubated for 15 min at 30 °C and
reactions were stopped by boiling for 5 min. cAMP content of each tube
was assayed for cAMP content by radioimmunoassay.
Intracellular Ca2 Measurements—Fibroblasts (0.25  105 cells)
were plated on 22-mm glass coverslips. The cells were washed once in
phosphate-buffered saline and incubated in 1 ml of DMEM containing
1 M Fura-2/AM at 37 °C for 30 min. Cells were then washed once with
DMEM and placed in a 37 °C chamber containing 1.5 ml of HEPES-
buffered saline (HBS: 130 mM NaCl, 5 mM KCl, 10 mM glucose, 1 mM
MgCl2, 1.0 mM CaCl2, 25 mM HEPES, pH 7.4), such that groups of 5–8
cells could be viewed using an inverted Olympus IX-70 microscope.
Spectrofluorometric measurements were collected using Delta Scan
System spectofluorometer (Photon Technology), where the field was
excited at 380 and 340 nm and the emission ratio was collected at 511
nm. Agonists were administered from 1000 stocks to maintain a
constant volume of 1.5 ml.
Reverse Transcriptase-PCR to Identify AC Isoforms—Total RNA was
extracted from cardiac fibroblasts grown to 80–90% confluency on
15-cm plates using Trizol reagent (Invitrogen). A DNase reaction was
performed to eliminate DNA contaminants and the RNA was reverse
transcribed using Superscript II (Invitrogen) and poly-T priming. Indi-
vidual isoform-selective primer pairs were used to amplify each isoform
of AC. Primers were based on rat or murine sequences as previously
described (24). PCR reactions with each primer pair were performed on
cDNA template, genomic DNA (positive control), and minus RT (nega-
tive control) template using 35 cycles and an annealing temperature of
56 °C. Sequence analysis was used to confirm the identity of all PCR
products.
Purification of Caveolin-enriched Membrane Fractions—Cardiac fi-
broblasts were fractionated using a detergent-free method adapted
from Song et al. (25), and described previously (22). The faint light-
scattering band resulting from sucrose density centrifugation was col-
lected from the 5–35% sucrose interface. The bottom 4 ml of the gradi-
ent (45% sucrose) was collected as non-caveolar membranes.
Immunoblot Analysis—Individual fractions or whole cell lysates
were separated by SDS-polyacrylamide gel electrophoresis (Nu-PAGE,
Invitrogen). Equal volumes of fractions were loaded so that each lane
represents similar proportions from the cells, resulting in 10-fold
lower amounts of protein loaded in the caveolin-enriched membrane
fraction lanes. Proteins were transferred to a polyvinylidene difluoride
membrane (Millipore) by electroblotting and probed with primary an-
tibody (see “Materials”). Bound primary antibodies were visualized by
chemiluminescence. Images of immunoblot analyses and RT-PCR are
representative of at least 3 separate experiments. In some experiments,
the optical density of bands was calculated using a digital imaging
system and LabWorks software (UVP Bioimaging Systems) and re-
ported as arbitrary optical density units.
Assay of Collagenase-sensitive [3H]Proline Incorporation—[3H]Pro-
line incorporation by cardiac fibroblasts was measured according to
modified methods of Guarda et al. (26). Briefly, cells were transferred to
12-well plates then were serum starved in 0% FBS for 24 h. Proline
incorporation was then assayed by adding 1 Ci/well of [3H]proline
(PerkinElmer Life Sciences) along with, where indicated, drugs of in-
terest and 2.5% FBS for 24 h. Cells were removed by trypsinization and
protein precipitated overnight with 20% trichloroacetic acid. Protein
was pelleted by centrifugation and washed 3 times with 1.0 ml of 5%
trichloroacetic acid  0.01% proline. Pellets were dissolved with 0.2 M
NaOH and the solutions titrated to neutral pH with 0.2 M HCl. Colla-
genase (2 mg/ml: Worthington Biochemical Corp.) in Tris/CaCl2/N-ethy-
maleimide buffer was added to each tube and samples were allowed to
incubate for 1 h at 37 °C. Samples were then placed on ice and proteins
were precipitated with 10% trichloroacetic acid for 1 h. Samples were
centrifuged at 14,000 rpm for 10 min and the collagenase-sensitive
[3H]proline in the supernatant was determined by liquid scintillation
counting.
Analysis of Data—Statistical comparisons (t tests and one-way anal-
ysis of variance) and graphics were performed using Graph Pad Prism
3.0 (GraphPad Software).
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RESULTS
Cross-talk between ANG II and AR Signaling Pathways Is
Mediated by Phospholipase C and Gq—Meszaros et al. (20)
have described that ANG II, perhaps acting via Gq, potentiates
AR and Gs-mediated cAMP production in cardiac fibroblasts.
In the first series of experiments we assessed whether cross-
talk between Gq and Gs was dependent upon Gq-promoted
phospholipase C (PLC) activity (promoted by Gq activation). We
incubated cardiac fibroblasts with the specific PLC inhibitor,
U73122, prior to hormonal stimulation with ANG II (100 nM) or
UTP (30 M) in combination with ISO (1 M, Fig. 1). UTP
provides a second class of agonist to assess cross-talk because it
is an efficacious activator of the Gq/PLC/inositol trisphosphate
pathway in these cells (20). Neither ANG II nor UTP alone
caused altered cAMP accumulation. At the concentration used
in these experiments, ISO routinely produces a 10–12-fold
increase in cAMP levels in cardiac fibroblasts (20). ANG II and
UTP potentiated the response to ISO by 1.8  0.1 and 2.0 
0.1-fold (relative to ISO alone), respectively. Whereas U73122
alone did not affect basal cAMP accumulation or the ISO re-
sponse, this inhibitor (at a concentration that reduced stimu-
lated phosphoinositide hydrolysis 75–80%) completely elimi-
nated the potentiation of cAMP accumulation by ANG II and
UTP. These data suggest that Gq-linked activation of PLC is
required for the effect of Gq potentiation of Gs-AC activity.
To assess whether activation of Gq might mediate the effects
of ANG II on AR signaling, we used adenoviral-mediated gene
transfer of Gq to increase its expression in cardiac fibroblasts
(Fig. 1B). Increased expression of Gq enhanced inositol phos-
phate accumulation by both ANG II (1.6-fold increase over
control) and UTP (2.6-fold increase over control) and signifi-
cantly enhanced the ANG II potentiation of ISO-stimulated
cAMP (3.9  0.5-fold over ISO alone) compared with control
cells incubated with the null (PACCMVpLpA) virus (2.5 
0.3-fold over ISO alone). Thus, results in Fig. 1 are consistent
with the conclusion that activation of GPCRs that activate Gq
and PLC enhance AR/Gs-mediated cAMP formation.
To determine whether signaling by G subunits generated
by activation of Gq mediates the observed cross-talk, we used
an adenovirus to express the C-terminal peptide of GRK2
(ARK1). This peptide (ARKct) binds to free G subunits,
and inhibits both G signaling and GRK2 activation (27). We
exposed cardiac fibroblasts to either ARKct or null virus and
measured cAMP accumulation stimulated by ISO with and
without ANG II. Expression of ARKct did not attenuate ANG
II-induced potentiation of ISO-stimulated cAMP accumulation
in cardiac fibroblasts (null virus: ISO 10.8 0.2-fold over basal,
ANG II  ISO 19.4  2.2; ARKct virus: ISO 9.2  0.5, ANG
II  ISO 20.8  0.6) but did induce a 4-fold increase in ISO
potency, consistent with its action blocking GRK2 activation
(27).
Another possible pathway by which ANG II could effect
cAMP production is via receptor tyrosine kinase signaling.
However, cross-talk was not inhibited in cells treated with
FIG. 1. Gq-Gs cross-talk is dependent upon Gq and PLC activation. A, cardiac fibroblasts were treated with PLC inhibitor U73122 (5 M)
for 5 min. Cells were co-stimulated with ANG II  ISO as well as with UTP  ISO. Cell lysates were extracted with 0.1 M HCl and cAMP was
determined by an enzyme-linked immunosorbent assay. Data are mean  S.E. expressed as fold-change over ISO. *, statistically significant
differences (p 0.01) by one-way analysis of variance. B, cardiac fibroblasts were infected with adenoviruses containing the lacZ gene (control) and
the wild-type  subunit of Gq (10 virus particles/cell) for 18–24 h prior to 15-min reactions and cAMP determinations. Data are mean  S.E.
expressed as fold-change over control. *, statistically significant differences versus control virus ANG II  ISO (p  0.01) by Student’s t test.
FIG. 2. Ionomycin-induced intracellular Ca2 transients enhance cAMP production. A, cardiac fibroblasts were loaded with Fura-2/AM
(1 M) and treated with the calcium ionophore ionomycin (IN) at varying concentrations. As anticipated, IN elevated cytosolic Ca2 in a
dose-dependent manner. The fluorescence ratios are representative data of 3 similar experiments. B, cells were co-treated with ISO  IN in the
presence of 0.1 mM isobutylmethylxanthine for 15 min at the indicated doses prior to cAMP measurements. Data are mean  S.E. expressed as
fold-change over ISO. Statistically significant differences were determined versus ISO alone by Student’s t test (*, p  0.05; **, p  0.01).
Ca2/CaM and AC Mediate Gq-Gs Cross-talk 24463
 by guest on June 23, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
AG1478 (10 M), a specific tyrosine kinase inhibitor (ANG II 
ISO, 2.0  0.1-fold over ISO alone; ANG II  ISO  AG1478
2.0 0.1) or with PP2 (1 M), a selective Src inhibitor (data not
shown). These findings and those of Fig. 1 indicate that ANG II
enhances ISO-mediated cAMP production via the action of Gq
and PLC rather than G or tyrosine kinase-associated signal-
FIG. 3. ANG II and ionomycin enhance forskolin-stimulated cAMP production. A, the cells were given varying concentrations of ANG
II in combination with 1 M forskolin (FSK) for 15 min prior to cAMP determinations. Data are mean  S.E. expressed as fold-change over control.
Statistically significant differences were determined versus FSK alone by one-way analysis of variance (*, p  0.05; **, p  0.001). B, cardiac
fibroblasts were co-treated with ionomycin (IN) 1 M FSK for 15 min and cAMP was determined. Data are mean S.E. expressed as fold-change
over control. *, statistically significant differences versus FSK alone (p  0.05) by Student’s t test.
FIG. 4. Intracellular Ca2 transients enhance cAMP production and are blocked by Ca2 chelation. A, cardiac fibroblasts were loaded with
1 M Fura-2/AM and the 340/380 fluorescence ratios were monitored. The cells were given varying concentrations of thapsigargin (TG), which produced
dose-dependent increases in intracellular Ca2. Data are representative of 3 similar experiments. B, cells were co-treated with similar doses of TG (as
in A) along with 1 M FSK. A dose-dependent increase in cAMP levels was observed with increasing concentrations of TG. Data are mean  S.E.
expressed as fold-change over control. *, statistically significant differences versus FSK alone (p  0.01) by Student’s t test. C, cells were incubated in
the absence and presence 1 M BAPTA/AM for 30 min prior to monitoring intracellular Ca2 levels in the presence of 100 M ANG II. BAPTA/AM
effectively buffers intracellular Ca2 levels when stimulated with 100 nM ANG II. Data are representative of three similar experiments. D, cardiac
fibroblasts were treated with 1 M BAPTA/AM for 30 min, and then with the indicated hormone treatments for 15 min. BAPTA/AM effectively blocked
the FSK/ANG II potentiation of cAMP. Data are mean  S.E. expressed as fold-change over control. *, statistically significant differences versus FSK
alone (p  0.01) by Student’s t test. **, statistically significant differences versus FSK  ANG II by Student’s t test (p  0.001).
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ing, an important distinction given that ANG II activates both
G protein and tyrosine kinase pathways in cardiac fibroblasts
(28, 29).
Requirement for Elevation of Intracellular Ca2 but Not
PKC—Because Gq activation by ANG II elevates intracellular
Ca2 levels and activates PKC in cardiac fibroblasts (29), we
examined the role of both responses as potential mechanisms
by which ANG II influences cross-talk with Gs. We utilized the
Ca2 ionophore, ionomycin, to elevate intracellular Ca2 levels
in a concentration-dependent manner (Fig. 2A) that synergis-
tically enhanced ISO-induced cAMP production (Fig. 2B) by
2.7  0.4 to 4.0  0.9-fold compared with ISO alone (indicated
by the dashed line) using 10 and 100 nM ionomycin, respec-
tively. Ionomycin alone did not alter basal cAMP production.
Conversely, pharmacological inhibition of PKC by GF109203X
(10 M) failed to inhibit the ANG II-induced potentiation of the
ISO response (ANG II ISO 2.0 0.1-fold over ISO alone, plus
GF109203X 1.9 0.1) but did reduce UTP-stimulated phospho-
extracellular signal regulated kinase immunoreactivity (basal,
36  6.1 OD; 100 M UTP, 1037  41; UTP  GF109203X,
180  14.4). Similar negative results were seen with the PKC
inhibitors calphostin C and staurosporine (data not shown).
Thus, Gq/Gs cross-talk appears to be mediated by the effect of
ANG II to elevate intracellular Ca2 and not activation of PKC.
ANG II and Ionomycin Potentiate Forskolin-induced cAMP
Production—To test whether the synergistic effects of ANG II
on ISO-stimulated cAMP formation might occur via an effect
distal to AR, we utilized forskolin, which directly activates AC
(albeit with some dependence upon Gs). Forskolin (1 M) alone
stimulated cAMP production by 8–10-fold over basal levels, a
level of response similar to that seen with 0.1–1 M ISO. ANG
II potentiated forskolin-induced cAMP levels (over forskolin
alone) in a concentration-dependent manner in the range
tested (1–100 nM), reaching statistical significance at 10 and
100 nM (1.6 and 2-fold over forskolin alone, respectively, Fig.
3A). Likewise, ionomycin (100 nM) significantly potentiated
forskolin-induced cAMP levels (from 8.3  1.3-fold alone to
25.5  7.4-fold in combination, relative to controls, Fig. 3B).
These results indicate that the effect of ANG II is distal to the
receptor and that ionomycin can mimic this effect by elevating
intracellular Ca2.
Effects of Ca2 Store Release and Ca2 Buffering on Gq-Gs
Cross-talk—We next sought to determine whether Gq-Gs cross-
talk might occur via Gq-promoted Ca
2 release from intracel-
lular stores and if we could inhibit the cross-talk by buffering
intracellular Ca2. Thapsigargin, which inhibits the sarcoen-
doplasmic reticular Ca2-ATPase pump, elevated intracellular
Ca2 levels in a concentration-dependent manner (Fig. 4A).
Thapsigargin at a concentration of 100 nM was maximally
efficacious in stimulating rapid Ca2 release; this concentra-
tion also synergistically enhanced forskolin-induced cAMP pro-
duction (Fig. 4B) with slight but statistically insignificant ef-
fects on basal cAMP production. We obtained similar results
when these experiments were performed in the absence of
extracellular Ca2 (data not shown), indicating that Ca2 re-
lease from internal stores was sufficient to observe the en-
hancement in cAMP formation. These results, together with
those from the studies with ionomycin, indicate that potentia-
tion of the cAMP signal can occur from elevation of intracellu-
lar Ca2, either by storage release or influx promoted by a Ca2
ionophore. Conversely, preincubation with 1 M BAPTA/AM for
30 min prior to agonist stimulation prevented ANG II-induced
Ca2 transients (Fig. 4C) and blocked the synergistic effects of
ANG II on forskolin-mediated cAMP production (Fig. 4D).
Thus, elevation of intracellular Ca2 is both necessary and
sufficient for potentiation of cAMP production by ANG II. The
results seen with forskolin indicate that Ca2 works at the
level of Gs/AC rather than AR.
AC Isoform Expression in Cardiac Fibroblasts—Because the
identity of AC isoforms expressed in cardiac fibroblasts could
result in specific signaling characteristics, we sought to define
the AC isoforms expressed in these cells and in particular to
assess isoforms that are regulated by Ca2. RT-PCR analysis
using isoform-specific primers revealed that cardiac fibroblasts
express mRNA for AC2, AC3, AC4, AC5, AC6, AC7, and AC8
(Fig. 5A). Each of the primer pairs amplified appropriate
genomic DNA sequence but did not yield PCR products when
RNA (no reverse transcriptase) was used as template (data not
shown). PCR reactions using primers for AC1 and AC9 yielded
products that were not of the expected size or sequence. We also
conducted immunoblot analysis to detect expression of AC pro-
teins. Because AC immunoreactivity in cardiac myocytes is
enriched in buoyant, caveolin-rich fractions in a manner that
improves immunological detection (22, 30), we fractionated
cardiac fibroblasts to isolate caveolin-rich fractions and per-
formed immunoblot analyses. As shown in Fig. 5B, caveolin-1
immunoreactivity was detected in buoyant fractions (caveolin-
rich fraction) and was excluded from non-buoyant fractions.
Immunoreactivity for AC3 and AC5/6 (the antibody used does
not distinguish between AC5 and AC6) was detected primarily
in caveolin-enriched membrane fractions, whereas immunore-
activity of AC2, AC4, and AC7 was detected only in non-cave-
olin-enriched membrane fractions (Fig. 5B). No immunoreac-
FIG. 5. Cardiac fibroblasts express multiple AC isoforms with
different subcellular distributions. A, RT-PCR analysis was per-
formed using AC isoform-specific primer pairs (see “Experimental Pro-
cedures”) and cDNA, mRNA (no reverse transcriptase negative control,
not shown), or genomic DNA (positive control, not shown). Arrows
indicate the size of the expected PCR product from each primer pair.
Image is representative of three experiments. B, expression of AC
isoforms was assessed by immunoblot analysis of caveolin-rich (cav)
and non-caveolin rich (non-cav) membrane fractions from cardiac fibro-
blasts (see “Experimental Procedures”). Each fraction was separated by
SDS-PAGE, transferred to membrane, and probed with antibodies spe-
cific for AC1, AC2, AC3, AC4, AC5/6, AC7, AC8, AC9, and caveolin 1.
Nonspecific immunoreactive bands are partially evident at the top of
images for AC5/6 and AC8. Each image is representative of at least
three experiments.
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tivity was detected for AC8 or AC9 (Fig. 5B). Thus, cardiac
fibroblasts express numerous AC isoforms but the isoforms
appear to be differentially localized in caveolin-rich membrane
microdomains.
AC Isoform Specificity of Gq-Gs Cross-talk—We hypothesized
that expression of a Ca2-calmodulin-stimulable isoform of AC
was essential for the cross-talk we observe. Thus, we pre-
treated cardiac fibroblasts with a specific calmodulin inhibitor
(10 M calmidazolium) and found that it significantly attenu-
ated cross-talk induced by ANG II plus ISO or by ionomycin
plus forskolin (Fig. 6, A and B, respectively). We also measured
Ca2 and forskolin-stimulated AC activity in membrane prep-
arations from cardiac fibroblasts with and without exogenously
added calmodulin; 3 M free Ca2 in the presence of forskolin
(10 M) did not stimulate AC activity unless calmodulin (0.1
M) was added to the reaction (Fig. 6C). This Ca2-stimulable
AC activity was inhibited by the inclusion of a calmodulin
inhibitor (1 M fluphenazine, which did not alter basal or
forskolin-stimulated AC activity). These results indicate that
Ca2-calmodulin activation of AC is a plausible mechanism for
the effect of ANG II and ionomycin to enhance cAMP produc-
tion by AR.
We next probed whether it was possible to attenuate cross-
talk between ANG II and cAMP production by altering the
balance of Ca2-stimulated versus Ca2-insensitive AC iso-
forms by using an adenovirus to overexpress an isoform of AC
that is not Ca2-stimulable, AC6 (14). Incubation of cardiac
fibroblasts with the AC6 adenovirus for 18 h resulted in a 2-fold
increase in maximal forskolin-stimulated cAMP production
(Fig. 6D). Based on evidence that the extent of AC overexpres-
sion is proportional to the increase in maximal forskolin re-
sponse (13), the conditions used here approximately doubled
the total cellular content of AC and generated cardiac fibro-
blasts expressing predominantly AC6. Immunoblot analyses
indicated an appreciable increase in detectible AC5/6 protein in
caveolin-enriched membrane fractions (Fig. 6D, inset). ANG II
FIG. 6. Calmidazolium and overexpression of AC6 inhibit cross-talk. A, cardiac fibroblasts were pretreated with the calmodulin inhibitor
calmidazolium (CDZ) for 30 min prior to reactions. The potentiation effect produced by the combination of ANG II and ISO was significantly
blocked in the presence of CDZ, but did not have a significant effect on ISO alone. Data are mean  S.E. expressed as fold-change over control.
*, statistically significant differences versus ANG II  ISO (*, p  0.05) by Student’s t test. B, cells were pretreated with CDZ for 30 min prior to
reactions. CDZ significantly inhibited cAMP potentiation induced by IN and FSK, but did not have a significant effect on FSK alone. Data are
mean  S.E. expressed as fold-change over control. *, statistically significant differences versus IN  FSK (*, p  0.05) by Student’s t test. C, AC
activity was measured in cardiac fibroblast membranes with or without calmodulin (0.1 M) and with or without fluphenazine (1 M). Data are
expressed as -fold over basal AC activity. #, statistically significant difference (p 0.05) versus Fsk alone; **, statistically significant difference (p
0.01) versus control by Student’s t test. D, production of cAMP in response to forskolin or forskolin plus ANG II was measured in control and
AC6-overexpressing cardiac fibroblasts. ANG II potentiation of FSK was significant (p 0.01) by Student’s t test) in control cells but not significant
(p  0.14) in AC6 overexpressing cells. Immunoblot analysis indicated an appreciable increase in AC5/6 protein in caveolin-enriched membrane
(Cav) fractions of cardiac fibroblasts incubated with AC6 adenovirus (inset).
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potentiation of forskolin-stimulated cAMP was unchanged by
AC6 overexpression in terms of absolute amount of cAMP stim-
ulated over forskolin alone (14.2  1.4 pmol of cAMP/mg of
protein in control cells versus 17.7  8.8 in AC6 cells), but was
significantly inhibited in terms of the fractional effect (p 
0.14, Fig. 6D). Thus, the potentiative effect of ANG II appeared
not to extend to the overexpressed AC6. The inability of ANG II
to potentiate forskolin-stimulated cAMP production to the
same degree in AC6-overexpressing cells was not related to a
limited capacity of cardiac fibroblasts to synthesize cAMP in
this latter condition, as combined treatment of the cells with
ISO and forskolin-stimulated cAMP levels to 27.6  3.48
pmol/mg protein, a level nearly 3-fold higher than the combi-
nation of forskolin and ANG II. Thus, cross-talk is decreased in
cells manipulated to express increased levels of AC6, an AC
isoform not activated by Ca2. Taken together, the data in Figs.
1–6 implicate the central role of both Ca2 influx and a Ca2-
calmodulin-stimulable AC isoform in mediating the observed
Gq-Gs cross-talk.
Role of Cross-talk on Collagen Synthesis—To investigate the
functional relevance of the cross-talk between ANG II signaling
and the cAMP pathway, we assessed the synthesis of collagen
by cardiac fibroblasts. Increased cellular cAMP levels can in-
hibit cardiac fibroblast-mediated production of collagen (31).
Thus, we tested whether simultaneous incubation with cAMP-
elevating agents and ANG II would inhibit collagen synthesis
to a greater extent than incubation with cAMP-elevating
agents alone. FBS-stimulated collagenase-sensitive [3H]pro-
line incorporation was measured in cardiac fibroblasts as an
index of collagen formation in the absence and presence of ANG
II and in the absence and presence of ISO. 2.5% FBS stimu-
lated collagen synthesis 2.6 0.2-fold over basal levels. ANG II
alone increased collagen synthesis (data not shown) but in the
presence of 2.5% FBS induced no significant increase over FBS
alone (Fig. 7A). ISO (100 M) inhibited FBS-stimulated colla-
gen synthesis (31 9% inhibition, Fig. 7, A and B). However, in
the presence of ANG II, ISO inhibited proline incorporation
48  8%, an effect that was significantly different (p  0.01)
from serum-stimulated levels (Fig. 7, A and B). Moreover, the
ANG II enhancement of the ISO effect was reduced to non-
significant levels by chelation of Ca2 (with 0.1 M BAPTA/AM)
or inhibition of calmodulin (with 0.1 M calmidazolium). Thus,
the data support the conclusion that the enhanced AR-medi-
ated cAMP production that ANG II promotes via elevation of
Ca2 and signaling via calmodulin can blunt collagen synthe-
sis. Taken together, the data suggest that coincidental Gs and
Gq signals interact to modulate cardiac fibroblast signaling and
function, and thereby promote a Gs-mediated inhibition of col-
lagen synthesis.
DISCUSSION
The focus of the present work was to define the mechanism of
Gq-Gs cross-talk, which we previously described in adult rat
cardiac fibroblasts (20). The striking potentiation of AR sig-
naling in the presence of ANG II might occur via several dif-
ferent mechanisms. ANG II activates AT1 receptors in cardiac
fibroblasts, thereby activating both Gq-coupled and tyrosine
kinase signaling pathways (28, 29). Several pieces of evidence
indicate that this cross-talk is mediated by activation of Gq: 1)
at least 2 other Gq-coupled receptors (P2Y and bradykinin) are
capable of inducing similar potentiation (Fig. 1A and Ref. 20);
2) blockade of PLC eliminates potentiation of ISO response by
either ANG II or UTP (Fig. 1A); 3) overexpression of Gq en-
hances cross-talk (Fig. 1B); 4) chelation of a key second mes-
senger of the Gq pathway, intracellular Ca
2, results in atten-
uation of cross-talk; and 5) pharmacological agents that
directly increase cytosolic Ca2 concentrations (ionomycin,
thapsigargin) also potentiate cAMP accumulation (Figs. 2 and
3). These data, along with evidence that exclusion of extracel-
lular Ca2 does not effect cross-talk (data not shown), indicate
that ANG II-induced potentiation of AR signaling is triggered
by Gq activation and Ca
2 release from internal stores and that
Ca2 influx is not required for enhanced cAMP production.
Consistent with this conclusion, pharmacological inhibition of
the other major pathway activated by Gq, PKC, had no effect on
cross-talk.
Our studies with forskolin allowed us to test the target at
which Ca2 acts to increase AR signaling. As a direct activa-
tor of AC, albeit requiring Gs activation for full effect (32),
forskolin-stimulated cAMP formation was also activated by
coincident signals that elevate intracellular Ca2 (e.g. ANG II,
ionomycin, or thapsigargin, Figs. 3 and 4). These results led us
to focus on the role of AC in Gq-Gs cross-talk. We were sur-
prised to discover that cardiac fibroblasts express mRNA for
seven of the nine transmembrane AC isoforms (Fig. 5). This
expression of multiple isoforms contrasts with results from
cardiac myocytes, which appear to express predominantly 2
isoforms, AC5 and AC6 (15). Of the isoforms expressed in
cardiac fibroblasts, the protein for AC3 appears to be predom-
inantly expressed, particularly in caveolin-rich fractions (Fig.
5B).
Given its level of expression and action as a Ca2-stimulable
isoform, AC3 is likely critical for the cross-talk that we observe
in cardiac fibroblasts. The other AC isoforms capable of being
activated by Ca2, AC1 and AC8, were not detected by immu-
noblot analysis (although AC8 mRNA was detected in PCR
studies). Previous data using heterologously expressed protein
indicate that AC3 stimulation by Ca2 is dependent upon co-
incidental activation of AC by either Gs or forskolin (18), re-
sults consistent with what we observe in cardiac fibroblasts. An
important role for a Ca2-stimulable AC isoform in the ob-
served cross-talk is inferred by data from vascular smooth
muscle (33) and directly supported by our studies overexpress-
ing AC6. By increasing AC6 expression, we altered the balance
of AC isoform expression in favor of an isoform not stimulated
by Ca2 and found that the Gq-Gs cross-talk was fractionally
reduced. Taken together, these data provide a clear-cut exam-
ple of AC isoform expression imparting distinct signaling char-
acteristics and regulation of cell function.
FIG. 7. Gq-Gs cross-talk impacts cardiac fibroblast collagen
synthesis. A, collagen synthesis, measured by collagenase-sensitive
[3H]proline incorporation as described under “Experimental Proce-
dures,” was stimulated by adding 2.5% FBS to serum-starved cells in
the absence and presence of ISO (100 M), ANG II (10 nM), or ISO plus
ANG II for 24 h. The Ca2 chelator BAPTA/AM (0.1 M) and the
calmodulin inhibitor calmidazolium (0.1 M) were also added in the
presence of ISO and ANG II. B, data for ISO, ISO plus ANGII, and
BAPTA/AM and calmidizolium are presented expressed as the percent
inhibition of the FBS-stimulated collagen synthesis. *, statistically
different p  0.05; **, p  0.01 by Student’s t test as compared with
2.5% FBS or FBS  ANG II stimulated, respectively.
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The membrane microdomains in which expression of AC
isoforms occurs can influence cell responses (22, 34). Caveolae
are a subset of lipid rafts, plasma membrane microdomains
enriched in sphingolipid and cholesterol, and are the site of
enrichment of many membrane-associated signaling molecules
(35). We found that among numerous AC isoforms expressed in
cardiac fibroblasts, only AC3 and AC5/6 localize in buoyant,
caveolin-rich domains. These data are the first of which we are
aware that show that native AC isoforms localize differently
with respect to caveolae/lipid rafts. Smith et al. (36) recently
reported that AC7 and AC8 heterologously expressed in HEK-
293 cells localized differently with respect to caveolin-rich do-
mains (AC8 in caveolar fractions, AC7 in non-caveolar frac-
tions). The reason for the difference between the data from
Smith et al. (36) and the present studies (we observe AC8 in
non-caveolar fractions, Fig. 5) is unclear, but localization of
GPCR and AC isoforms in caveolar fractions can be highly
cell-specific and can differ between exogenously and endog-
enously expressed protein (24). More work is needed to under-
stand the functional importance, if any, of the observed pattern
of AC isoform expression in different plasma membrane mi-
crodomains of these cells.
Our studies of collagen synthesis (Fig. 7) suggest the physi-
ological importance of Gq-Gs cross-talk. Agents that elevate
cellular cAMP attenuate collagen synthesis by cardiac fibro-
blasts (5). In our studies, ISO alone (in the absence of a phos-
phodiesterase inhibitor) could significantly inhibit collagen
synthesis, and the addition of ANG II, which produced a 2-fold
increase in ISO-stimulated cAMP accumulation, led to a
greater reduction in collagen synthesis. These results appear to
conflict with observations that AR antagonists can reduce
fibrosis in heart failure (37, 38). However, the beneficial effects
of AR blockade are likely dominated by improvements in
cardiac contractility (which would lead to decreased levels of
renin-angiotensin and possibly other hormones) and myocyte
survival, which in turn influence ECM formation and turnover
as well as fibroblast proliferation. Our findings are consistent
with data on certain other Gs-linked agonist action on cardiac
fibroblasts (31, 39) and with a previous report that the AR
antagonist, propranolol, inhibits collagen deposition in pulmo-
nary fibroblasts, cells not subjected to the mechanical forces of
a contractile organ (40). In addition, our studies examine fibro-
blasts over a short period (24 h) and in isolation, removed from
circulating catecholamines and the mechanical forces of cardiac
contraction.
In conclusion, the current results demonstrate that ANG II
enhances AR signaling via activation of Gq and elevated in-
tracellular Ca2. We propose that a Ca2-stimulable isoform of
AC, likely AC3, is the regulatory site of this Ca2/calmodulin-
dependent potentiation and acts as an integrator of these sig-
naling pathways. Moreover, cross-talk between the Gq and Gs
pathways (i.e. enhanced cAMP production) appears to have
functional consequences for regulation of the ECM in myocar-
dium, acting to limit collagen synthesis.
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Angiotensin II enhances adenylyl cyclase signaling via
Ca2/calmodulin. Gq-Gs cross-talk regulates collagen
production in cardiac fibroblasts.
Rennolds S. Ostrom, Jennifer E. Naugle, Miki Hase, Caroline
Gregorian, James S. Swaney, Paul A. Insel, Laurence L.
Brunton, and J. Gary Meszaros
Page 24465: In Fig. 5 of this paper, we analyzed the localiza-
tion of natively expressed isoforms of adenylyl cyclase (AC) in
buoyant, caveolin-rich fractions from rat cardiac fibroblasts
isolated on a discontinuous sucrose gradient. Fig. 5 shows and
under “Results” we state that immunoreactivity to AC8 and
AC9 was not detected. However, under “Discussion,” we mis-
takenly stated that we observed AC8 immunoreactivity in non-
caveolin-rich fractions. While a minority of our studies revealed
a small amount of AC8 immunoreactivity in non-caveolin-rich
fractions, our results were neither definitive nor consistent
enough for us to conclude that AC8 is expressed in non-
caveolin-rich fractions. Therefore, we conclude that AC8 pro-
tein is not detectable in cardiac fibroblasts by the methods that
we have employed.
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